2016 ISHLT Annual Meeting and Scientific Sessions

Apr 27, 2016 ‐ Apr 30, 2016


Standard: $250.00

Sessions

PRE-MEETING SYMPOSIUM 03: Current Innovations and Future of EVLP -- The Future of Lung Repair - Cell and Gene Interventions during EVLP Mechanisms of Injury

Apr 27, 2016 8:20am ‐ Apr 27, 2016 8:35am

Identification: PMSY03b

This symposia will explore the prospect of gene, cell, drug and molecular interventions during EVLP to improve outcomes for lung transplant recipients. How essential EVLP is to the running of a modern day program will be debated.

Speaker(s):
  • Shaf Keshavjee, MD, FRCSC, Toronto General Hospital, Toronto, ON, Canada

PRE-MEETING SYMPOSIUM 04: Under Pressure: Pulmonary Hypertension in Parenchymal Lung Disease -- Shrinking with Age: The Role of Telomerases in ILD and PH-ILD

Apr 27, 2016 8:20am ‐ Apr 27, 2016 8:35am

Identification: PMSY04b

Cardiothoracic transplantation for patients with HIV, and hepatitis B and C remains a controversial topic. Historically, infection with any of these viruses was considered a relative or even absolute contraindication for transplantation. However, favorable experience in liver and kidney recipients has led some programs to progressively adjust selection criteria. The recent ISHLT listing criteria guidelines now include HIV, HCV and HBV positive patients and more programs are performing transplantation in these complex populations. Having a current understanding of these diseases, therapy and monitoring will assist the transplant team.  This includes knowledge of drug interactions and the concerns for the various types of  immunosuppression (Induction, maintenance) on these patients and if there are preferred agents to use.  Lastly developing an approach with an understanding of how to manage complications is necessary for success. Therefore, the focus of this symposium is to increase the knowledge of the CT transplant community about the management and pharmacological treatment options for CT transplants candidates with HIV, hepatitis B or C, before and after transplant.

Speaker(s):

PRE-MEETING SYMPOSIUM 06: Back to the Future: Cell Therapy for Thoracic Organ Failure and Transplant? -- Cell Therapy for the Failing Organ: Patch Up the Heart

Apr 27, 2016 8:20am ‐ Apr 27, 2016 8:35am

Identification: PMSY06b

This session will focus on cutting edge therapies that involve cells. There will be a focus on using cells to repair or fully regenerate a failing organ, for transplant tolerance induction or treatment of chronic rejection.

Speaker(s):

PRE-MEETING SYMPOSIUM 07: The Future is Here: Emerging Issues in Infectious Disease -- RSV and the Paramyxoviruses: Should We Treat?

Apr 27, 2016 8:20am ‐ Apr 27, 2016 8:35am

Identification: PMSY07b

This symposium will explore the emergence and resurgence of difficult to treat pathogens in thoracic transplant and MCSD patients that challenge practitioners worldwide.

Speaker(s):

PRE-MEETING SYMPOSIUM 01: Anticoagulation and MCS: Can We Do Better? -- Who Should Be Monitoring INR and How?

Apr 27, 2016 8:40am ‐ Apr 27, 2016 8:55am

Identification: PMSY01c

The goal of this symposium is to familiarize clinicians with current, widely available tests of blood coagulability and pitfalls in their interpretation in the MCS population. Additional topics will include comorbid states, such as acquired von Willebrand’s disease and genetic variations like Factor V mutations, and how they impact patients after device implantation.

Speaker(s):
  • Anna Meyer, MD, Leipzig Heart Center, Leipzig, Germany

PRE-MEETING SYMPOSIUM 02: Controversies in Heart Transplantation: Past, Present and Future -- DEBATE: Cardiac Biopsy is Essential for Post-transplant Rejection Surveillance (PRO)

Apr 27, 2016 8:40am ‐ Apr 27, 2016 8:55am

Identification: PMSY02c

This session will review current immunosuppressant pharmacology as well as the current status of rejection surveillance. The utility of endomyocardial biopsy will be debated and then a report on future of heart transplant immunosuppression will be presented including perspectives on where the next advances will come from.

Speaker(s):

PRE-MEETING SYMPOSIUM 03: Current Innovations and Future of EVLP -- The Future of Lung Preservation Techniques

Apr 27, 2016 8:40am ‐ Apr 27, 2016 8:55am

Identification: PMSY03c

This symposia will explore the prospect of gene, cell, drug and molecular interventions during EVLP to improve outcomes for lung transplant recipients. How essential EVLP is to the running of a modern day program will be debated.

Speaker(s):

PRE-MEETING SYMPOSIUM 04: Under Pressure: Pulmonary Hypertension in Parenchymal Lung Disease -- Connective Tissue Disease PH-ILD: Which One Matters?

Apr 27, 2016 8:40am ‐ Apr 27, 2016 8:55am

Identification: PMSY04c

Cardiothoracic transplantation for patients with HIV, and hepatitis B and C remains a controversial topic. Historically, infection with any of these viruses was considered a relative or even absolute contraindication for transplantation. However, favorable experience in liver and kidney recipients has led some programs to progressively adjust selection criteria. The recent ISHLT listing criteria guidelines now include HIV, HCV and HBV positive patients and more programs are performing transplantation in these complex populations. Having a current understanding of these diseases, therapy and monitoring will assist the transplant team.  This includes knowledge of drug interactions and the concerns for the various types of  immunosuppression (Induction, maintenance) on these patients and if there are preferred agents to use.  Lastly developing an approach with an understanding of how to manage complications is necessary for success. Therefore, the focus of this symposium is to increase the knowledge of the CT transplant community about the management and pharmacological treatment options for CT transplants candidates with HIV, hepatitis B or C, before and after transplant.

Speaker(s):
  • Jerome Le Pavec, MD, Hôpital Marie Lannelongue, Le Plessis Robinson, France

PRE-MEETING SYMPOSIUM 05: Making It Work: Heart Transplant Challenges from the Surgeon's Perspective -- When Great Vessels Go Bad Following Transplantation

Apr 27, 2016 8:40am ‐ Apr 27, 2016 9:00am

Identification: PMSY05c

To discuss the controversies, advances, and new directions in heart transplant surgery.

Speaker(s):

PRE-MEETING SYMPOSIUM 06: Back to the Future: Cell Therapy for Thoracic Organ Failure and Transplant? -- Cell Manipulation for Transplant Tolerance

Apr 27, 2016 8:40am ‐ Apr 27, 2016 8:55am

Identification: PMSY06c

This session will focus on cutting edge therapies that involve cells. There will be a focus on using cells to repair or fully regenerate a failing organ, for transplant tolerance induction or treatment of chronic rejection.

Speaker(s):
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content